A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey

被引:54
|
作者
Ozgoztasi, O [1 ]
Baydar, I [1 ]
机构
[1] GAZIANTEP UNIV,DEPT DERMATOL & INFECT DIS,GAZIANTEP,TURKEY
关键词
D O I
10.1046/j.1365-4362.1997.00022.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
An open-labeled, randomized clinical trial to evaluate the efficacy of paromomycin ointment as compared with ketoconazole was conducted on seventy-two patients of both sexes and different ages with the confirmed diagnosis of cutaneous leishmaniasis (CL). All patients had a complete clinical evaluation for other diseases. Patients were excluded if they were pregnant or nursing or if they had serious concomitant diseases. Patients were divided randomly into two treatment groups: in the first group 40 patients were treated with an ointment containing 15% paromomycin sulfate and 12% methylbenzothonium chloride in white soft paraffin (labeled as p-ointment by El-On(1)) twice daily for 15 days. Treated lesions were left uncovered. The second group consisted of 32 patients who received ketoconazole 400 mg/day orally for 30 days. This dosage was reduced to 200 mg/day for patients below 12 years of age. In all cases the diagnosis was based on positive smear and/or culture. Direct smears were prepared from the exudate obtained by a small incision made at the edge of the lesion with a sterile surgical blade or lancet and stained using the Giemsa method for leishmania bodies (Pig. 1). In smear negative and suspected cases aspirates taken by puncturing the lesions were inoculated onto NNN (Novy, McNeal, Nicolle) medium for culture. The cultures were incubated at 28 degrees C and the development of motile promastigotes was observed. Clinical and parasitological evaluations of the patients were performed at the end of the treatment period and 4 weeks post-treatment. A cure was defined as complete healing and disappearance of the lesion or reversible hypopigmentation at the site of lesion. Incomplete or partial improvement was defined as a reduction in the size of a lesion and the absence of parasites on smear or culture. A treatment failure was defined as the absence of any changes in the lesion and persistence of parasites on smear or culture.
引用
下载
收藏
页码:61 / 63
页数:3
相关论文
共 50 条
  • [21] Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis
    Moosavi, Z
    Nakhli, A
    Rassaii, S
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2005, 44 (12) : 1064 - 1065
  • [22] A DOUBLE-BLIND CLINICAL-TRIAL OF THE TREATMENT OF CUTANEOUS LEISHMANIASIS WITH PAROMOMYCIN OINTMENT
    ELSAFI, SH
    MURPHY, AG
    BRYCESON, ADM
    NEAL, RA
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1990, 84 (05) : 690 - 691
  • [23] Comparing the efficacy of fluconazole and cryotherapy Versus cryotherapy alone on treating cutaneous leishmaniasis: a triple-blind randomized clinical trial
    Parhizkar, Ahmad Reza
    Sharafi, Mehdi
    Mansuri, Susan
    Hadibarhaghtalab, Maryam
    Afrashteh, Sima
    Fatemian, Hossein
    Chijan, Mahsa Rostami
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [24] Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial
    Sharma, Namrata
    Singhal, Deepali
    Maharana, Prafulla K.
    Sinha, Rajesh
    Agarwal, Tushar
    Upadhyay, Ashish D.
    Velpandian, Thirumurthy
    Satpathy, Gita
    Titiyal, Jeewan S.
    CORNEA, 2017, 36 (12) : 1521 - 1527
  • [25] Comparing the efficacy of fluconazole and cryotherapy Versus cryotherapy alone on treating cutaneous leishmaniasis: a triple-blind randomized clinical trial
    Ahmad Reza Parhizkar
    Mehdi Sharafi
    Susan Mansuri
    Maryam Hadibarhaghtalab
    Sima Afrashteh
    Hossein Fatemian
    Mahsa Rostami Chijan
    BMC Infectious Diseases, 24
  • [26] Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin
    Grogl, M
    Schuster, BG
    Ellis, WY
    Berman, JD
    JOURNAL OF PARASITOLOGY, 1999, 85 (02) : 354 - 359
  • [27] EFFECT OF TOPICAL PAROMOMYCIN ON CELL-MEDIATED-IMMUNITY DURING CUTANEOUS LEISHMANIASIS
    FRANKENBURG, S
    GROSS, A
    JONAS, F
    KLAUS, S
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (01) : 68 - 70
  • [28] Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches
    de Sa, Fernando A. P.
    Andrade, Jayanaraian F. M.
    Miranda, Thamires C.
    Cunha-Filho, Marcilio
    Gelfuso, Guilherme M.
    Lapteva, Maria
    Kalia, Yogeshvar N.
    Gratieri, Tais
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 648
  • [29] TOPICAL TREATMENT OF RECURRENT CUTANEOUS LEISHMANIASIS WITH OINTMENT CONTAINING PAROMOMYCIN AND METHYLBENZETHONIUM CHLORIDE
    ELON, J
    WEINRAUCH, L
    LIVSHIN, R
    EVENPAZ, Z
    JACOBS, GP
    BRITISH MEDICAL JOURNAL, 1985, 291 (6497): : 704 - 705
  • [30] Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial
    Ezzatt, Ola M.
    Helmy, Iman M.
    CLINICAL ORAL INVESTIGATIONS, 2019, 23 (02) : 947 - 956